NDT Advance Access published online on September 12, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl505
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, University of Alberta, Department of Critical Care, University of Alberta, Institute of Health Economics and Department of Public Health Sciences, University of Alberta, Edmonton, Canada
* To whom correspondence should be addressed.
Editorial Comment
Do statins protect the kidney as well as the heart?
Marcello Tonelli 1 *
Marcello Tonelli, E-mail: mtonelli{at}ualberta.ca
This article has no Abstract.
Keywords:
Statins; CKD; PREVEND Study.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Ritz and C. Wanner Lipid Abnormalities and Cardiovascular Risk in Renal Disease J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1065 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Furumatsu, Y. Nagasawa, T. Hamano, H. Iwatani, K. Iio, T. Shoji, T. Ito, Y. Tsubakihara, and E. Imai Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan Nephrol. Dial. Transplant., March 1, 2008; 23(3): 984 - 990. [Abstract] [Full Text] [PDF] |
||||

